Pages that link to "Q53243461"
Jump to navigation
Jump to search
The following pages link to Contribution of asymmetric synapse loss to lateralizing clinical deficits in frontotemporal dementias. (Q53243461):
Displaying 25 items.
- The hippocampus in schizophrenia: a review of the neuropathological evidence and its pathophysiological implications (Q33979202) (← links)
- Early calcium dysregulation in Alzheimer's disease: setting the stage for synaptic dysfunction (Q34203241) (← links)
- CHMP2B mutants linked to frontotemporal dementia impair maturation of dendritic spines. (Q34454439) (← links)
- Is synaptic loss a unique hallmark of Alzheimer's disease? (Q34504659) (← links)
- Synapse loss in dementias (Q34748678) (← links)
- p53 prevents neurodegeneration by regulating synaptic genes. (Q34753015) (← links)
- Valosin-containing protein and neurofibromin interact to regulate dendritic spine density (Q35578562) (← links)
- COPS5 protein overexpression increases amyloid plaque burden, decreases spinophilin-immunoreactive puncta, and exacerbates learning and memory deficits in the mouse brain (Q35580909) (← links)
- cAMP-Inhibits Cytoplasmic Phospholipase A₂ and Protects Neurons against Amyloid-β-Induced Synapse Damage (Q36105758) (← links)
- Frontotemporal lobar degeneration with TDP-43 proteinopathy and chromosome 9p repeat expansion in C9ORF72: clinicopathologic correlation (Q36253321) (← links)
- Protecting the synapse: evidence for a rational strategy to treat HIV-1 associated neurologic disease. (Q37015379) (← links)
- The role of tau in neurodegeneration (Q37145919) (← links)
- CSF biomarkers in frontotemporal lobar degeneration with known pathology (Q37253492) (← links)
- Review: disruption of the postsynaptic density in Alzheimer's disease and other neurodegenerative dementias (Q37790804) (← links)
- Synaptic changes in frontotemporal lobar degeneration: correlation with MAPT haplotype and APOE genotype. (Q39817807) (← links)
- Phospholipase A2 inhibitors protect against prion and Abeta mediated synapse degeneration. (Q40395313) (← links)
- Sialic Acid within the Glycosylphosphatidylinositol Anchor Targets the Cellular Prion Protein to Synapses (Q41045723) (← links)
- Monoacylated Cellular Prion Proteins Reduce Amyloid-β-Induced Activation of Cytoplasmic Phospholipase A2 and Synapse Damage (Q41148512) (← links)
- Astrocytes and glutamate homoeostasis in Alzheimer's disease: a decrease in glutamine synthetase, but not in glutamate transporter-1, in the prefrontal cortex (Q41861166) (← links)
- Yeast as a model system to study tau biology. (Q42729005) (← links)
- Polyunsaturated fatty acids protect against prion-mediated synapse damage in vitro. (Q45915360) (← links)
- Diagnostic Accuracy of MRI and Additional [18F]FDG-PET for Behavioral Variant Frontotemporal Dementia in Patients with Late Onset Behavioral Changes (Q47990209) (← links)
- Synapse loss is greater in presenile than senile onset Alzheimer disease: implications for the cognitive reserve hypothesis (Q48582964) (← links)
- Decreased neprilysin immunoreactivity in Alzheimer disease, but not in pathological aging (Q48887111) (← links)
- Lipopolysaccharide-induced neuroinflammation induces presynaptic disruption through a direct action on brain tissue involving microglia-derived interleukin 1 beta (Q64265598) (← links)